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Abstract
Background: Like in several other Western countries, in the Dutch health care system regulated competition has been 
introduced. In order to make this work, comparable information is required about the performance of health care 
providers in terms of effectiveness, safety and patient experiences. Without further coordination, external actors will all 
try to force health care providers to be transparent. For health care providers this might result in a situation in which 
they have to deliver data for several sets of indicators, defined by different actors. Therefore, in the Netherlands an effort 
is made to define national sets of performance indicators and related measuring instruments. In this article, the 
following questions are addressed, using patient experiences as an example:
- When and how are stakeholders involved in the development of indicators and instruments that measure the
patients' experiences with health care providers?
- Does this involvement lead to indicators and instruments that match stakeholders' information needs?
Discussion: The Dutch experiences show that it is possible to implement national indicator sets and to reach 
consensus about what needs to be measured. Preliminary evaluations show that for health care providers and health 
insurers the benefits of standardization outweigh the possible loss of tailor-made information. However, it has also 
become clear that particular attention should be given to the participation of patient/consumer organisations.
Summary: Stakeholder involvement is complex and time-consuming. However, it is the only way to balance the 
information needs of all the parties that ask for and benefit from transparency, without frustrating the health care 
system.
Background
Introduction
Several other Western countries, for example the United
States, look at the Dutch healthcare system as an example
[1,2]. In the Netherlands, regulated competition has been
introduced in healthcare. In order to make this competi-
tion work, transparency is required [3]. Consumers and
health insurers or other purchasing agencies need com-
parable information about the performance of health care
providers in terms of effectiveness, safety and patient
experiences. Apart from that, transparency is also
required from the point of view of public accountability
[4,5].
In centralised, state-oriented systems like the English
National Health Service (NHS), government or govern-
ment agencies impose national sets of performance indi-
cators with which health care providers have to comply.
The English Care Quality Commission asks "all NHS
organisations to assess their performance against the
Government's 24 core Standards for Better Health" [6].
However, in pluralistic systems like the United States, or
in social insurance systems like the Netherlands, quality
standards are not likely to be imposed by government,
and the definition of indicator sets requires much more
coordination and negotiation among the actors in the
health care system.
In the United States, standardized indicator sets are
developed by private not-for-profit organizations, such as
the Joint Commission [7] and the National Committee
for Quality Assurance (NCQA). The NCQA, for example,
aims to build consensus among large employers, policy-
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makers, medical professionals, patients and health insur-
ers to decide how to measure important aspects of quality
of care. The NCQA is responsible for the management of
the Healthcare Effectiveness Data and Information Set
(HEDIS), a set of standardized performance indicators.
HEDIS is used by more than 90% of health plans through-
out the United States [8]. According to the American
NCQA, consensus about indicators and measurement
instruments is necessary, because transformation of the
health care system requires the collective will and
resources of all the actors involved: employers (in the
American context), policymakers, professionals, patients
and health insurers [9].
In the Dutch system, private, mostly not-for-profit
organisations and self-employed private practitioners,
provide health care. In a system of regulated markets,
these organisations and practitioners are theoretically
assumed to compete with each other for health insurance
contracts and for individual patients. As such, they have
an incentive to advertise and to give potential consumers
information about specific products or services. How-
ever, market forces do not generate comparative informa-
tion without external pressure. In the Netherlands, this
external pressure can theoretically be exercised by several
actors: the Ministry of Health, the Inspectorate for
Health Care, the Dutch Healthcare Authority ("Neder-
landse Zorgautoriteit"), health insurers, and/or patient/
consumer organisations.
Without further coordination, all these external actors
will try to force health care providers to be transparent.
For health care providers this might result in a situation
in which they have to deliver data for several sets of indi-
cators, defined by different actors. To avoid this situation,
the main challenge for the Dutch health care system cur-
rently is to stimulate health care providers to be transpar-
ent about those indicators that are relevant for the
Inspectorate for Health Care, health insurers and
patients/consumers alike. However, at the same time the
amount of data and the number of indicators that provid-
ers have to deliver, should be limited.
In the Netherlands, the performance of health care pro-
viders is measured in terms of effectiveness and safety (in
the Dutch context these are called 'professional indica-
tors'), and patient experiences with quality aspects such
as access, timeliness, information and communication,
respectful treatment etc. A strong effort is made to define
national sets of performance indicators and related mea-
suring instruments. In the Dutch setting, these national
indicator sets are agreed upon by all the stakeholders
involved in the transparency debate. This should decrease
the administrative burden on health care providers. Col-
lecting information on performance indicators is time-
consuming, costly and generally requires the cooperation
of health care providers. However, by using national indi-
cator sets, information has to be collected once and can
then be used for multiple purposes.
Because of the desire to define indicator sets, not from
the perspective of one dominant actor (such as the Gov-
ernment in England), but from the shared perspective of
all parties involved, stakeholder participation and con-
sensus building is a key aspect of defining national indica-
tor sets in the Netherlands. In this article, we shall
address the following questions, using patient experi-
ences as an example:
- When and how are stakeholders involved in the devel-
opment of indicators and instruments that measure the
patients' experiences with health care providers?
- Does this involvement lead to indicators and instru-
ments that match stakeholders' information needs?
In other words: is it possible to reach consensus about
what needs to be measured and still cover enough of the
information needs of various stakeholders to prevent
them from developing their own, tailor-made indicator
sets? The answer to this question is relevant for research-
ers and policy makers involved in indicator development.
This article is based on desk research and observations
by the authors. It should be noted that the authors are
also personally involved in the transparency debate and
the development of indicators and instruments namely as
director (DD) of the Dutch Centre for Consumer Experi-
ence in Health Care ("Centrum Klantervaring Zorg"), as
h e a d  o f  t h e  N I V E L  r e s e a r c h  d e p a r t m e n t  i n v o l v e d  i n
developing measuring instruments for patient experi-
ences (JR), and as director of NIVEL (PG).
Indicators in the Dutch health care system
Patient experiences are measured using patient surveys.
As part of the policy effort aimed at defining national
indicator sets, a standardized method for measuring
patient experiences using patient surveys is being pro-
moted by the Ministry of Health, the Inspectorate for
Health Care ("Inspectie voor de Gezondheidszorg"),
patient/consumer organisations and by insurance compa-
nies. This standardized method is called the Consumer
Quality Index (CQI). Before describing stakeholder
involvement in CQI development, in this section, back-
ground information is provided on:
• the reforms in the Dutch health care system;
• the CQI, as a standardized method for measuring
patient experiences
• the information needs of stakeholders.
Regulated competition in the Dutch health care system
In the Dutch health care system, three regulated interde-
pendent markets have been introduced: a health insur-
ance market, a purchasing market, and a health care
market. Detailed information and a video about the
Dutch health care system and the reforms can be foundDelnoij et al. BMC Health Services Research 2010, 10:88
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on the website of the Ministry of Health, Welfare and
Sport [10]. Here we shall give a brief overview.
The  health insurance market has been introduced
nationwide in 2006 with the introduction of a new insur-
ance system [11,12]. Health insurers offer a uniform,
basic benefits package that includes primary care, hospi-
tal care, prescription medication, and allied health ser-
vices such as speech therapy, or physiotherapy for people
with chronic diseases. In addition to that, enrolees can
take out supplementary insurance, for example for addi-
tional physiotherapy (the provision of which is limited
under the basic benefits package), dental care, etc. Con-
sumers have free choice of health insurer and can switch
once a year. Health insurers are obliged to accept every-
one for the basic benefits package. The premium for the
basic benefits package must be based on community rat-
ing, that is, different health insurers charge different pre-
m i u m s ,  b u t  h e a l t h  i n s u r e r s  m u s t  c h a r g e  t h e  s a m e
premium for all their insured with a specific insurance
policy. In other words, insurers are not allowed to differ-
entiate premiums according to the risks of individuals or
subgroups. However, they are allowed to offer different
insurance policies that may be tuned to the needs of spe-
cific subgroups of consumers. The most important differ-
ence in insurance policies is between those based on
direct payment (guaranteeing the enrolee access to health
care providers who are contracted by the health insurer),
and those based on restitution (guaranteeing full or par-
tial reimbursement of health care costs incurred by the
enrolee).
On the purchasing market, the system aims to provide
health insurers with incentives to contract high quality,
low-priced health services [13]. This is particularly the
case for insurance policies based on direct payment. As a
result, it also confronts health insurers with a need for
comparative information about the performance of
health care providers. They can use this information for
selective contracting with preferred providers, and for
pay-for-performance contracts aimed at stimulating spe-
cific professional behaviour.
On the health care market, consumers with a restitu-
tion policy have free choice of providers. Those with a
policy based on direct payment can choose from an -usu-
ally- comprehensive list of contracted providers. In such a
system, patients/consumers too need comparative infor-
mation about the price and quality of care, in terms of the
effectiveness and safety of health services, and patient
experiences with access and availability, timeliness, infor-
mation etc [14].
Consumer Quality Index
In 2006, the CQI has been proposed by the Ministry of
Health, Welfare and Sports as the national standard for
measuring patient experiences with health care providers
and health plans. CQI is a registered trademark that is
owned by the Centre for Consumer Experience in Health
Care ("Centrum Klantervaring Zorg"). This Centre is a
private foundation with a tripartite board (with members
from patient/consumer organisations, health insurers,
and health care providers), funded by the Ministry of
Health, Welfare and Sports. The CQI trademark is used
to certify that information about the performance of
health care providers is valid, reliable, and comparable.
The trademark indicates that the information has been
collected with an official CQI patient survey, by a certi-
fied 'survey vendor' according to rules and instructions
described in the CQI Manual [15]. The Centre for Con-
sumer Experience in Health Care coordinates the devel-
opment of CQI surveys and it coordinates data collection
with those questionnaires. CQI surveys are developed
with both public and private funding. Public funding is
used to develop surveys with a high public priority, e.g. in
terms of quantity (incidence, prevalence and burden of
disease), costs of illness, or in terms of market conditions
(based on the extent to which the type of care addressed
in the survey is subject to regulated competition). How-
ever, data collection is mostly privately funded by health
insurers or health care providers who are willing to par-
ticipate in development projects.
The CQI is based on two principles: the CAHPS [16]
method and the QUOTE [17] method. Both instruments
measure patient experiences rather than patient satisfac-
tion. Patient experience questionnaires ask whether cer-
tain processes and events occurred. In the CQI, this
inventory of experiences is combined with questions
about values and expectations with regard to health care.
For example: patients are asked to report how often in the
past 12 months doctors explained things in a way they
could understand (never, sometimes, usually or always).
In addition, they are asked how important it is to them,
that doctors explain things in a way they could under-
stand (on a 4-point scale from 'not important' to 'of the
utmost importance'). Combining questions about experi-
ences as well as importance makes it possible to weigh
negative experiences. This is helpful in determining pri-
orities for quality improvement by providers. Improve-
ment strategies should target those areas that are very
important to patients, but with which they have relatively
bad experiences. For informed patient choice, the impor-
tance items are irrelevant. Individual patients seeking
information about providers or treatments weight experi-
ences of others against their own priorities. Insurance
organisations might use information about the impor-
tance people attach to aspects of care or service in their
purchasing policies.
Currently sixteen CQI questionnaires have been devel-
oped for several curative services (such as cataract sur-
gery [18], total hip and total knee arthroplasty [19]), for
chronic illnesses (such as diabetes [20]), for health insur-
ance, for general practice, for physiotherapy, for long-Delnoij et al. BMC Health Services Research 2010, 10:88
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term nursing care, and for ambulatory mental health
care. In addition to those, another 20 questionnaires are
being developed for future use. These include emergency
care, care for people with disabilities, inpatient mental
health care, veteran health care, cancer care etc. The pro-
cess of developing a CQI is described in detail in the CQI
Manual of the Centre for Consumer Experience in Health
Care.
CQI questionnaires are developed in public-private
partnerships. The research part of the development proj-
ect is usually commissioned and funded by public actors,
mainly the Ministry of Health, Welfare and Sports and/or
the Netherlands organisation for health research and
development ("ZonMw"). However, the data collection
necessary for the empirical testing of the questionnaires
under construction is financed from private sources, i.e.
by health care insurers or by health care providers. The
data are owned by these private financiers, but the
researchers are granted access to the data in order to con-
duct psychometric and other statistical analyses that are
required to validate the instruments. Because large data
sets are required to test the discriminative power of CQI
instruments, i.e. to test whether an instrument is able to
detect differences in the performance of health care pro-
viders, the costs of data collection are considerable and
generally constitute about half of the total development
costs. Total development costs of one CQI instrument
can amount up to € 200,000.
Who wants to know what and why?
In health services research in general, and particularly in
areas such as indicator development it is important to
define from the start what the purpose of an indicator is.
In other words, the question to be kept in mind is "Who
wants to know what and why?" If we apply this question
to the quality of care of health care providers, different
stakeholders have different information needs. As we
explained earlier, the performance of health care provid-
ers is measured in terms of effectiveness, safety, and
patient experiences.
As long as information needs are discussed in such
highly abstract terms, parties can quite easily agree on
sets of indicators. If stakeholders disagree, they usually do
so about the best operationalisation of certain indicators.
T ake the simple example of an indicator such as "avail-
ability of hospital beds". Described as such, this indicator
of access and availability may be relevant for several
stakeholders, including individual consumers, patient
organisations, health insurers, and the Ministry of
Health. However, when it comes to operationalising it,
the Ministry of Health might ask for the number of beds
per 1,000 of the population and perhaps for regional dif-
ferences in this number. Health insurers may be inter-
ested in bed occupancy rates per provider, because they
w a n t  t o  k n o w  w h e r e  t h ey  c a n  b u y  a d d i t i o n a l  s e rv i c e s.
Moreover, for an individual consumer, it is very irrelevant
how many beds a certain hospital has. He or she needs
only one bed and all that matters is when that bed
becomes available.
Also within one group of stakeholders, information
needs may differ profoundly. For example, 'the' health
care consumer does not exist. People have different pref-
erences and not everyone is keen on making deliberate
choices when it comes to health care. Choice is exercised
more often by younger, healthier and better-educated
patients than by the older, sicker and less well educated
[21]. Health literacy and patient activation are important
factors that are related to patients' intentions and possi-
bilities to act as an informed consumer [22,23]. However,
even among those who do choose, different groups can be
identified. Schwartz [24] distinguishes between consum-
ers who are satisficers and maximizers. Satisficers settle
f o r  s o m e t h i n g  t h a t  i s  g o o d  e n o u g h  a n d  d o  n o t  w o r r y
about the possibility that there might be a better option.
Maximizers seek and accept only the best. It is feasible to
assume that the two stereotypes have different informa-
tion needs. Maximizers are interested in finding out who
is the best provider. Satisficers will be more inclined to
stick with their usual, local provider but may want to
know how this provider performs compared to others.
Consumers looking for the 'best provider' may apply dif-
ferent criteria to determine what the 'best' is. Groe-
newoud [25] for example, found empirical evidence for
the existence of two types of consumers: those who focus
on outcomes, and those who focus on trust.
Another example of different information needs within
one group of stakeholders is between insurance compa-
nies who engage in selective contracts and insurance
companies who strive for pay-for-performance contracts.
Selective contracting requires comparative information,
because health insurers want to contract the best and/or
the cheapest providers. Pay-for-performance contracts
may require information about current performance in
relation to external norms or past performance, depend-
ing on the type of incentives used [26]. In general, differ-
ent incentives used call for the application of different
statistical techniques, but also for different accents in the
measuring instruments used. From the point of view of
selective contracting, an indicator on which all providers
score equally bad is not interesting. Nevertheless, in a
pay-for-performance scheme this indicator might well be
the focus of attention, because there is much room for
improvement.
The information needs of different stakeholders in the
Dutch health care system with regard to the performance
of health care providers are summarized in Table 1. The
description of information needs in this Table is partly
derived from the literature [21-26] and is partly based on
the observations of the authors. Considering the differ-
ences in information requirements of the various stake-Delnoij et al. BMC Health Services Research 2010, 10:88
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holders, their involvement in indicator development is
necessary to make sure that their information needs are
met as efficiently and appropriately as possible.
Stakeholder involvement: when and how
In developmental health services research, such as the
development of indicators and the related measuring
instruments, it is recommended that researchers and
stakeholders meet, debate and cooperate throughout the
different phases of a study [27]. Through this process, the
results are a co-production. This ensures that informa-
tion needs are met, which enhances the utilization of the
findings. In the development of CQI patient experience
questionnaires, there are three phases in which a dialogue
between researchers and stakeholders is vital:
- the preparatory phase in which the initial policy prob-
lem is transformed or translated into a 'researchable'
question;
- the construction phase in which abstract information
needs are operationalised in the form of questionnaire
items with specific answering categories;
- and the reporting phase in which crude data are being
presented in the form of report cards, quality information
or policy reports.
These phases are visualised in Figure 1. In the remain-
der of this section, we shall describe the dialogue between
researchers and stakeholders in these three phases with
respect to the measurement of patient experiences in the
Netherlands.
Preparatory phase (transformation)
Although the publication of comparative information
about consumer experiences with health care providers is
a vital condition for the functioning of the health care
market, the Dutch Ministry of Health, Welfare and Sports
has refrained from a central policy concerning the prod-
ucts or providers that should be covered by CQI patient
surveys. This is deliberately left to the responsibility of
the main actors in health care. The Ministry has mainly
determined the process along which decisions about sur-
vey development should be taken, namely through tripar-
tite so-called national Steering Committees in which
national representatives of patient/consumer organisa-
tions, of health care providers and of health insurers
should participate. These Steering Committees are
installed by the Ministry and are supported by a secretar-
iat resorting under the Inspectorate for Health Care (an
autonomous department of the Ministry). The Steering
Committees' objectives are to negotiate and implement
national agreements per health sector about indicators
for external accountability.
Steering Committees have been installed with respect
to care for the disabled, long-term nursing care (nursing
homes, homes for the elderly, home care), mental health
care, hospital care, general practice, physiotherapy and
pharmaceutical care. Steering Committees do not only
determine which indicators are to be made public by
every health care provider, but also how and how often
these indicators should be measured. In doing so, Steer-
ing Committees can commission and use research on
indicator and survey development. CQI patient surveys
that have been commissioned by Steering Committees
Table 1: Information needs of different stakeholders: Who 
wants to know what?
Who What
Individual consumers Maximizers: Who is the best 
provider for me (in terms of 
outcomes or in terms of 
trust)? Where can I find this 
provider? Do I have access (in 
terms of waiting times, 
insurance coverage etc.)?
Satisficers: How does my 
usual provider perform 
compared to others?
Patient/consumer 
organisations
Do providers meet quality 
standards as defined by 
patient/consumer 
organisations? Which areas 
of performance are lacking 
behind (and therefore need 
special focus in our 
lobbying)? How can we help 
members/patients to make 
an informed choice?
Health insurers Do providers meet 
predefined quality standards 
(pay-for-performance)? 
Whom shall we (not) contract 
from the quality perspective 
(preferred providers)?
Health care providers What are best practices? 
Which areas of our 
performance need 
improvement? What do 
patients and insurers expect 
from us?
Inspectorate for Health Care Which providers perform 
below a minimum quality 
level (and therefore need 
further inspection)?
Ministry of Health What is the overall level of 
quality of care in the 
Netherlands and how does it 
develop over time?Delnoij et al. BMC Health Services Research 2010, 10:88
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are the CQI Care for the disabled, the CQI Long-term
Nursing Care, and the CQI Mental health care.
However, questionnaire development is also initiated
by parties outside Steering Committees, particularly in
sectors for which Steering Committees have only recently
been installed (the CQI pharmaceutical care, the CQI
general practice, and the CQI physiotherapy), for chroni-
cally ill who use care across various sectors (the CQI Dia-
betes, the CQI Rheumatoid Arthritis, the CQI Asthma,
the CQI COPD), and for particular services that are sub-
Figure 1 The research cycle in indicator development (source: adapted from Bensing et al 2001 [41]).
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ject to selective contracting by health insurers (the CQI
Cataract, the CQI THA/TKA, the CQI Breast Cancer
Care). The initiators of these CQI surveys that are not
commissioned by Steering Committees are often health
insurers who use the information about patient experi-
ences in their strategic purchasing, but also patient/con-
sumer organisations who need this information for their
lobbying and advocacy.
Construction phase (operationalisation)
CQI surveys are aimed at measuring the quality of care as
experienced by health care users. For that reason, the
development of every CQI instrument starts with at least
two focus group discussions with 8 to 12 patients
recruited from the specific target group. Ideally, partici-
pants in these focus groups are more or less representa-
tive for the target group. In these groups, discussions take
place about how patients define good quality of care, and
about their concrete experiences with distinct aspects of
health care quality. The focus group discussions lead to
an operationalisation of quality of care from the patients'
perspective and are aimed at ensuring the content validity
of the questionnaires.
Typically, the first focus group discussions result in
long lists of possible questionnaire items. These long lists
contain mostly process aspects of health care quality (e.g.
information, communication and interpersonal contact).
It is not altogether clear why so few aspects of technical
quality and outcomes are mentioned. One of the reasons
might be that patients are not necessarily aware of the
fact that the technical quality of care varies between doc-
tors and between hospitals. They might take effectiveness
and safety of care for granted and, therefore, they are not
inclined to mention these aspects explicitly. Furthermore,
although they are the ones who experience the outcomes
of health care interventions, for patients it is difficult to
evaluate the technical quality of these interventions. For
this reason too, technical aspects may not be mentioned
in focus group discussions.
In subsequent group discussions, the long lists of items
are reduced to short lists that form the basis of the first
draft of a questionnaire. Through these qualitative
research methods, individual patients are involved in the
construction phase of a new CQI questionnaire.
Apart from that involvement, the development of a
CQI questionnaire is guided by tripartite working groups
meeting 4 to 6 times during the project. If a CQI is devel-
oped on the initiative of a Steering Committee, usually,
this Steering Committee also installs the working group.
In other cases, the Centre for Consumer Experience in
Health Care or the research institute responsible for the
development of the questionnaire installs the working
group.
Members of the working groups are recruited from
health insurers, health care providers and patient or con-
sumer organisations. Typically, a working group consists
of about ten members: at least two representatives from
each party (patient or consumer organisations, providers,
and insurers), two or three researchers, and a representa-
tive of the Centre for Consumer Experience in Health
Care. Working groups are tripartite in the sense that
members are recruited from the three parties in health
care. However, those parties do not necessarily have
equal numbers of representatives in the working group.
The number of representatives per party depends on
practical issues and on the topic of the CQI question-
naire. If the questionnaire is about one specific type of
provider, then the number of providers participating in
the working group is relatively small. For example, in the
working group for the CQI Physiotherapy there were only
two physiotherapists. However, if the questionnaire
addresses episodes of care for a certain chronic condition,
the number of providers involved is usually much larger.
The working group may then include professionals from
different disciplines (e.g. general practitioners, special-
ists, nurses, or allied health professionals).
As a rule, working group members have practical
knowledge of the health care sector or the disease under
study. For example, the working group for the develop-
ment of the CQI Rheumatoid Arthritis included:
- the medical advisors of a few large health insurance
companies;
- a rheumatologist involved in guideline development
within the scientific association of rheumatologists;
- two representatives of the rheumatoid arthritis patient
organisation (one staff member of the central bureau of
this organisation, and one patient who was active as a vol-
unteer within the organisation).
Although working group members are recruited from
insurers, providers and patient organisations, they do not
always act as delegates or representatives. They are
invited to join the working group for instance because of
their involvement in earlier, similar efforts e.g. in the field
of indicator development. Particularly medical doctors
have often participated in a working group without a for-
mal mandate and feedback from their respective scien-
tific associations.
Generally, the working groups meet at least four times:
- At the start of a development project, when the pre-
cise scope of the questionnaire is being discussed and
decisions are taken about defining the population, sam-
pling strategy and in-/exclusion criteria. In some cases,
an additional meeting is necessary to define the technical
details of the sampling strategy.
- Before the first version of the questionnaire is empiri-
cally tested, to help researchers with the exact formula-Delnoij et al. BMC Health Services Research 2010, 10:88
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tion of questions, the translation of complicated medical
terms in to lay language etc.
- After the empirical test, to evaluate the outcomes and
the reliability and validity of the questionnaire, and to dis-
cuss adaptation of the questionnaire in order to improve
the psychometric properties and shorten it by discarding
superfluous questions, questions with a high item non-
response etc.
- At the end of the project, to discuss and approve the
research report about the development process, possible
other information products (e.g. quality reports or con-
sumer information) and the final version of the question-
naire.
Sometimes, a questionnaire needs to be revised so fun-
damentally that it takes two extra meetings to address all
the changes. This is also the case if parties within a work-
ing group have different opinions of the scope and pur-
pose of a questionnaire. In those cases, it takes longer to
come to agreement within the working group. This con-
sensus building is crucial in the construction phase of a
questionnaire. Working groups do not apply formal
methods for consensus building, but rather follow some
general principles. The empirical test results serve as
guidance in this process. Items that are extremely skewed,
have a high item non-response, do not discriminate
between health care providers or do not belong to a reli-
able scale are 'candidates' for deletion. However, working
group members may argue to keep some of these items, if
they can convince the other parties that these items pro-
vide actionable results, are vital to their information need
or may become relevant in the near future. In decision
about single items, the patient perspective has a certain
primacy in the sense that items that result from focus
group discussions with patients may not be deleted on
the request of health care providers or health insurers.
Presentation
Whereas in the phase of 'transformation' and 'operation-
alisation' consensus between the various stakeholders is
required, this consensus is not essential when it comes to
decisions about the presentation format of CQI data. In
the CQI Manuals, three types of information products
are described: consumer report cards, purchasing infor-
mation for insurers and quality reports for health care
managers and professionals. These products can be
adapted to the information needs of the different stake-
holders. In the Netherlands, several studies are currently
being conducted around the question how performance
information should be presented to various stakeholders
in order to best support their decision-making.
The studies with respect to consumer report cards
build on earlier work done in the United States by the
research group of Hibbard and colleagues [28-31]. Con-
cerning consumer report cards, the Centre for Consumer
Experience in Health Care has issued elaborate guidelines
for presentation formats. These guidelines are based on
the examples of CAHPS consumer reports [32], on stud-
ies by Hibbard and on empirical research in the Nether-
lands, testing various formats in consumer panels [33].
Consumer report cards present information about the
relative performance of healthcare providers in the form
of stars (* = below average, ** = average, *** = above aver-
age). Performance is generally measured on the level of
so-called themes (scales consisting of a number of under-
lying questionnaire items). For consumers who wish to
see more in-depth information, additional bar charts can
be presented.
As long as parties agree that information is valid and
reliable, stakeholders do not necessarily have to agree on
the exact content, presentation format and mode of
release of CQI data [cf. [34]]. However, consensus is nec-
essary about the timing of publicity. Often, this is decided
in Steering Committees. Decisions may be prepared by
the CQI working group. However, in sectors where Steer-
ing Committees are active, these Committees ultimately
decide on the indicators to be measured, the measuring
instruments to be used and the frequency of measure-
ment. They also decide on the indicators that are to be
made public. However, Steering Committees differ in the
degree to which they take responsibility for the presenta-
tion format of public performance indicators. For exam-
ple, the Steering Committee on mental health care has
chosen to ensure that data become publicly available, but
not to decide on the presentation format of indicators. In
contrast, the Steering Committee on long-term nursing
care went so far as to determine which indicators were to
be made public, on which level of aggregation, and in
which format. On the basis of a study [35] commissioned
by the Inspectorate for Health Care (one of the partici-
pants in the Steering Committee) they chose to present
the consumer information in the form of report cards
using 1 to 5 stars, representing performance below or far
below average to above or far above average. For feedback
reports to providers, the Steering Committee chose to
present performance scores that reflected actual versus
expected performance.
In addition to data collected on the initiative of Steering
Committees, health insurers conduct CQI surveys. To
t h a t  e n d ,  t h e y  h a v e  e s t a b l i s h e d  a  f o r m a l  c o o p e r a t i o n ,
called the Miletus Foundation ("Stichting Miletus"), in
which they pool money for data collection in the develop-
mental phase of an instrument, as well as for data collec-
tion with validated questionnaires. The surveys
commissioned by the Miletus Foundation usually have
nationwide coverage, because all the Dutch health insur-
ers participate in Miletus. That implies that Miletus CQI
surveys can be used to construct public consumer infor-
mation. The Centre for Consumer Experience in HealthDelnoij et al. BMC Health Services Research 2010, 10:88
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Care and the Miletus Foundation have formally agreed
that:
• Performance data from nationwide Miletus CQI
surveys are published as consumer information no
later than 6 months after the health insurers have
received the internal reports on which they base their
contracting decisions;
• Consumer information is prepared according to the
guidelines issued in the CQI Manuals.
Discussion
The questions addressed in this article were: When and
how are stakeholders involved in the development of
indicators and instruments that measure patient experi-
ences with health care providers? Does this involvement
lead to indicators and instruments that match stakehold-
ers' information needs?
With respect to the first question, it can be concluded
that the involvement takes the form of tripartite stake-
holder representation both on the policy level (Steering
Committees) and on the operational level (working
groups participating in questionnaire development).
With respect to the second question, we argue that this
involvement is a prerequisite for collecting information
once and using it for multiple purposes. However, a
potential risk is that it leads to the development of
extremely long questionnaires. We will elaborate on this
topic in the next subsection about the operational level.
First, we shall address stakeholder involvement on the
policy level.
Policy level
The Steering Committees decide on the indicators to be
published, the measuring instruments to be used and the
frequency of measurement. Although Steering Commit-
tees are assisted by a secretariat and although they have
budgets at their disposal for research, advice, instrument
development and data processing, there is no legal basis
for Steering Committees' decisions. Therefore, the
authority of a Steering Committee depends heavily on the
mandate of the participants in the committee. This sys-
tem of obligatory voluntarism works (so far), because the
Dutch health care system has a long tradition of central
negotiations by national representatives who have a man-
date to make binding decisions. However, it is somewhat
at odds with a system of regulated competition and prog-
ress is often slow, particularly in the curative care sector
(hospitals, GPs).
Although Steering Committees are a promising route
towards transparency in the Dutch health care system,
this strategy has certain inherent disadvantages. One dis-
advantage is that Steering Committees operate per health
care sector, e.g. long-term care, hospital care, or mental
health care. The result is that indicators are being devel-
oped within the traditional boundaries of health care pro-
vision. Moreover, they are being developed first in those
sectors where Steering Committees have been installed
first, for example in long-term care. These are not neces-
sarily the same areas of health care that matter most from
a public health or an economic perspective.
For example, coronary heart diseases, heart failure and
stroke are in the Dutch top-10 diseases with the highest
burden of disease [36]. Yet, for those patient groups there
is no CQI instrument available.
Similarly, the provider-specific CQI questionnaires that
are developed on the initiative of Steering Committees do
not necessarily cover those areas that are of interest to
health insurers. From the point of view of providers,
accounting for the quality of care they have delivered in
exchange for public funding, the natural unit of analysis is
the level of the hospital, or the mental health institution,
or the home care provider. However, from the point of
view of health insurers, data segmented along the tradi-
tional boundaries of health care sectors are often not
informative. For example, health insurers can purchase
m e n ta l heal t h ca r e fr o m  hosp itals, fr o m  me n tal  hea lt h
institutions, or from self-employed private psychiatrists
and psychotherapists. From that point of view, it is much
more interesting to know which one of these providers
performs best in treating e.g. depression or anxiety disor-
ders. The unit of analysis in that case is not the organisa-
tion, but a specific patient group within several
organisational settings, and ultimately the performance
of an individual medical specialist.
In general, health insurers are interested in comparing
the disease-specific or intervention-specific perfor-
mance of providers, even across the borders of the tradi-
tional sectors such as hospital care, mental health care, or
primary care. Therefore, health insurers initiate the
development of CQI questionnaires in areas that are not
taken up by the national Steering Committees. Insurers
request the Netherlands organisation for health research
and development to fund the development research.
Health insurers themselves pay for the data collection
through their Miletus Foundation. CQI questionnaires
that have been initiated by the Miletus Foundation are,
for instance, the CQI Diabetes, the CQI Cataract surgery,
the CQI THA/TKA, and the CQI Mobility & Hearing
Aides. If health insurers use these questionnaires, they
draw samples from their own claims registration (e.g.
selecting insured that have been reimbursed for cataract
surgery) and organize the data collection, analysis and
report without bothering health care providers. There-
fore, in that sense, the development, testing and use of
these CQI developments does not lead to additional
information demands on health care providers. However,
health insurers do invite health care providers and patient
organisations to their working groups that assistDelnoij et al. BMC Health Services Research 2010, 10:88
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researchers during questionnaire development and test-
ing, thus adding to the burden of representation
demands. This overload of representation demands is
experienced by the various scientific associations of spe-
cialists, but particularly by patient/consumer organisa-
tions, whose staff members and volunteers do not only
simply lack the time to attend all the meetings, but often
also lack the scientific and managerial competences that
are essential for fruitful participation [37].
Operational level
When a CQI instrument is being developed, a working
group is installed in which 'representatives' of health
insurers, health care providers and patients/consumers
participate. It is our observation in these working groups,
that representatives of health insurers are often interested
in:
- comparatively global information;
- disease-specific or intervention-specific;
- aggregated to the level of contractual partners (e.g. a
hospital group, or a chain of diabetes providers);
- on a variety of domains, not only patients' experiences
with the quality of the process of care (the items emerg-
ing from focus group discussions), but also patients' expe-
riences with the outcome of care ('has your THA/TKA
had the expected result?').
Compared to insurers, health care providers want more
detailed information on a lower level of aggregation (e.g.
the hospital ward instead of the hospital at large). More-
over, contrary to insurers, health care providers usually
resent the use of retrospectively measured patient
reported outcomes, as invalid measures of the quality of
care. In response to this, the Centre for Consumer Expe-
rience in Health Care and researchers involved in devel-
oping CQI instruments are currently investigating this
research domain, looking particularly at recent develop-
ments in this area in the English NHS [38]. However, the
problem might be conceptual rather than technical. In
one CQI development project surgeons argued that the
word "quality of care" should consistently be deleted in
the research report, because patient experiences -in their
opinion- measure something completely different than
quality of care. Even after the researchers insisted that the
CQI measures quality of care "from the patient's perspec-
tive", this remained a topic of debate. The notion that
patient experiences are an integral part of the quality of
care is apparently not accepted throughout the medical
profession.
In general, working group members provide valuable
input in all the phases of the process and they are an
indispensable source of information for researchers.
However, for the acceptation and implementation of a
CQI instrument, the fact that working group members
are not always official 'representatives' of their group, can
be a drawback. The CQI instruments about diabetes, cat-
aract surgery, THA/TKA, breast cancer care, and rheu-
matoid arthritis have all been developed together with
medical doctors, but have not been officially approved or
adopted by their scientific associations.
This means that there is a missing link between the
operational level and the policy level. At present, this
missing link is both a blessing and a curse. It is a blessing,
because it makes it possible to continue the development
of questionnaires together with specialists, although at
the same time on the policy level in the national steering
committee, the umbrella organisation of medical special-
ists is -at best- neutral towards measuring patient experi-
ences and is certainly not one of its frontline advocates.
However, in the end this lack of formal commitment is
probably a curse. The whole idea behind introducing a
national standard for measuring patient experiences was
that we would collect this information once and then use
it for multiple purposes. In other words, not only for
external accountability, but also for internal quality assur-
ance. The latter use implies that professionals should
have a sense of ownership with respect to the CQI instru-
ment. This sense of ownership would improve if the ques-
tionnaires were formally adopted by the professional
organisations.
Recognition of CQI instruments by the medical profes-
sion implies that these professionals accept the notion
that patient experiences are an independent but integral
part of the quality of care, alongside the technical quality
that is captured by indicators of effectiveness and safety.
Patient experiences and patient-centred care are not only
important in long-term nursing care, where respectful
and sensitive interpersonal contact should be core busi-
ness. This is also important in curative care, where good
clinical decision making implies that patients' values and
preferences are taken into account and that patients are
adequately informed about treatment options and their
pros and cons. Partly, the hesitation of medical doctors to
acknowledge the value of patient experience surveys
stems from their conviction that patients are unable to
evaluate the technical quality of care. However, Coulter
[39] argues that well designed questionnaires for patients
can contribute usefully to an assessment of both the tech-
nical competence and interpersonal skills of doctors.
Stakeholder involvement is a prerequisite for collecting
information once and using it for multiple purposes.
Through stakeholder involvement, we aim to incorporate
the information needs of all the potential users of CQI
information. However, if those information needs do not
fully match, researchers run the risk of developing
extremely long questionnaires, that contain all the ques-
tions that every stakeholder might possibly at some point
in the future be interested in. After all, in comparatively
short research projects with hard deadlines, it is easier to
add everyone's questions to the questionnaire, than toDelnoij et al. BMC Health Services Research 2010, 10:88
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negotiate with working group members about a core set
until consensus has been reached.
This is one of the paradoxes of standardisation. One
aims to make one questionnaire that everybody can use,
and ends up with something the size of two or more ques-
tionnaires. In the CQI, this development is now followed
by an effort to make both short and longer versions of the
same questionnaire, where the short version can be used
for example to make comparative consumer information
and the long version can be used for internal quality
improvement. However, essentially, this is one-step away
from the original purpose.
So, is it possible in performance measurement to reach
consensus about what needs to be measured, and still
cover enough of the information needs of various stake-
holders to prevent them from developing their own, tai-
lor-made indicator sets? Although the Dutch process of
developing national indicator sets is still in full swing, we
can draw some preliminary conclusions with respect to
measuring patient experiences. In our opinion, the sheer
number of CQI instruments that has been and still is
being developed shows that it is possible to reach consen-
sus about what needs to be measured. Increasingly, CQI
instruments are being used instead of a variety of other
surveys that were previously used to measure patient
experiences or patient satisfaction. Often, this happens to
the detriment of the researchers and survey vendors
working with these surveys. Preliminary evaluations
show that for health care providers and health insurers
the benefits of standardization outweigh the possible loss
of tailor-made information [40]. However, our observa-
tions could be biased by the fact that opponents of the
standardized CQI method might not share their views
with us. As we stated in the beginning of this paper, we
are personally involved -as researchers- in the develop-
ment of indicators and instruments.
Conclusion
Consensus about what needs to be measured in perfor-
mance assessment, is necessary to prevent that health
care providers have to deliver data for several sets of indi-
cators, defined by different actors. Consensus can be
build through stakeholder involvement in the definition
of indicators and measuring instruments.
Our experiences so far show that in this process, partic-
ular attention should be given to the participation of
medical professionals and of patient/consumer organisa-
tions. In the case of medical professionals, a link must be
established between the working group member and his
or her scientific association. Moreover, in development
projects the time schedule must leave room for formal
feedback of scientific associations on draft instruments.
Currently, research projects are carried out under too
many time constraints. In the case of patient/consumer
organisations, an extensive programme of support should
be implemented, to allow these organisations to not only
attend meetings, but to also participate in the scientific
discussions and to imprint the "patient's perspective" in
every CQI questionnaire.
Stakeholder involvement is complex and time-consum-
ing. However, it is the only way to balance the informa-
tion needs of all the parties that ask for and benefit from
transparency, without frustrating the health care system.
The resulting standardization enables contract partners
(health care providers and health insurers) to move away
from discussions about the validity of indicators and
instruments towards discussions about the quality of
care.
Summary
In the Dutch health care system regulated competition
has been introduced. In such a system, several actors
need comparable information about the performance of
health care providers. Without further coordination,
these actors will force health care providers to be trans-
parent. For health care providers this might result in a sit-
uation in which they have to deliver data for several sets
of indicators, defined by different actors: patient or con-
sumer organisations, health insurers, policy makers, or
'watchdogs' such as the Inspectorate for Health Care. To
prevent this, an effort is made to define national sets of
performance indicators and related measuring instru-
ments. In this article, we have described how are stake-
holders involved in the development of indicators and
instruments that measure the patients' experiences with
h e a l t h  c a r e  p r o v i d e r s .  T h e  q u e s t i o n  i s  w h e t h e r  t h i s
involvement leads to indicators and instruments that
match stakeholders' information needs. The Dutch expe-
riences show that it is possible to implement national
indicator sets and to reach consensus about what needs
to be measured. Preliminary evaluations show that
although stakeholder involvement is complex and time-
consuming, the benefits of standardization outweigh the
possible loss of tailor-made information.
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